Growth Differentiation Factor‐15 Deficiency Inhibits Atherosclerosis Progression by Regulating Interleukin‐6–Dependent Inflammatory Response to Vascular Injury
Open Access
- 29 November 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Heart Association
- Vol. 1 (6), e002550
- https://doi.org/10.1161/jaha.112.002550
Abstract
Background: Growth differentiation factor ( GDF )‐15 is a distant and divergent member of the transforming growth factor‐β superfamily (TGF‐β) . There is growing evidence indicating the involvement of GDF ‐15 in various pathologies. Expression of GDF ‐15 is induced under conditions of inflammation and increased GDF ‐15 serum levels are suggested as a risk factor for cardiovascular diseases. Methods and Results: We show here that GDF ‐15 and proinflammatory cytokine interleukin ( IL )‐6 levels are highly increased (5‐fold) in cultured oxidized low‐density lipoproteins–stimulated peritoneal macrophages derived from GDF ‐15 +/+ /apolipoprotein (apo) E −/− , mice. Notably, IL ‐6 induction on oxidized low‐density lipoproteins stimulation is completely abolished in the absence of GDF ‐15. Consistent with our in vitro data GDF ‐15 mRNA expression and protein levels are upregulated (2.5‐ to 6‐fold) in the atherosclerotic vessel wall of GDF ‐15 +/+ /apo E −/− mice after a cholesterol‐enriched diet. GDF ‐15 deficiency inhibits lumen stenosis (52%) and 18 FDG uptake (34%) in the aortic arch despite increased serum triglyceride/cholesterol levels and elevated body weight. Immunohistomorphometric investigations of atherosclerotic lesions reveal a decreased percentage of inflammatory CD 11b + (57%) or IL ‐6 + , leukocytes, and apoptotic cells (74%) after 20 weeks. However, the total number of macrophages and cell density in atherosclerotic lesions of the innominate artery are increased in GDF ‐15 −/− /apo E −/− mice. Conclusions: Our data suggest that GDF ‐15 is involved in orchestrating atherosclerotic lesion progression by regulating apoptotic cell death and IL ‐6–dependent inflammatory responses to vascular injury.Keywords
This publication has 46 references indexed in Scilit:
- Novel biomarkers in cardiovascular disease: Update 2010American Heart Journal, 2010
- Consequences and Therapeutic Implications of Macrophage Apoptosis in AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- The Transforming Growth Factor-β Family Members Bone Morphogenetic Protein-2 and Macrophage Inhibitory Cytokine-1 as Mediators of the Antiangiogenic Activity of N-(4-Hydroxyphenyl)RetinamideClinical Cancer Research, 2005
- Impact of Interleukin-6 on Plaque Development and Morphology in Experimental AtherosclerosisCirculation, 2004
- Cyclooxygenase Inhibitors Induce the Expression of the Tumor Suppressor Gene EGR-1, Which Results in the Up-Regulation of NAG-1, an Antitumorigenic ProteinMolecular Pharmacology, 2004
- Expression of growth differentiation factor‐15/ macrophage inhibitory cytokine‐1 (GDF‐15/MIC‐1) in the perinatal, adult, and injured rat brainJournal of Comparative Neurology, 2001
- GDF-15/MIC-1 a novel member of the TGF-ß superfamilyPublished by Springer Science and Business Media LLC ,2000
- Interleukin-6 Exacerbates Early Atherosclerosis in MiceArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Expression of a novel member of the TGF-β superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissuesCell and tissue research, 1999
- Expression of Interleukin-6 in Atherosclerotic Lesions of Male ApoE-Knockout MiceArteriosclerosis, Thrombosis, and Vascular Biology, 1998